< Back to previous page
Researcher
Simon De Meyer
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Cardiovascular Sciences, Kulak Kortrijk Campus (Department)
Responsible
From1 Aug 2015 → Today - Cardiovascular Sciences, Kulak Kortrijk Campus (Department)
Member
From1 Jan 2013 → Today - Biomedical Sciences Group, Kulak Kortrijk Campus (Section)
Member
From1 Oct 2012 → 31 Dec 2012 - Chemistry, Kulak Kortrijk Campus (Department)
Member
From1 Oct 2010 → 30 Sep 2012 - Faculty of Science, Kulak Kortrijk Campus (Faculty)
Member
From1 Oct 2001 → 30 Sep 2010
Projects
31 - 40 of 43
- Neutrophil extracellular traps: a novel target in acute ischemic stroke?From1 Jan 2015 → 1 Sep 2017Funding: FWO Strategic Basic Research Grant
- Towards long-term correction of severe von Willebrand disease via non-viral Sleeping Beauty transposon gene therapy.From1 Jan 2015 → 31 Dec 2018Funding: FWO research project
- Immunoprofiling of patients with acquired thrombotic thrombocytopenic purpura: towards identification of prognostic factors.From1 Jan 2015 → 31 Dec 2018Funding: IWT personal funding - strategic basic research grants
- Novel prothrombolytic strategies for the treatment of ischemic stroke.From1 Oct 2014 → 30 Sep 2019Funding: BOF - Concerted Research Project from 1994
- State-of-the art tools for non-viral gene therapy: towards long-term correction for von Willebrand disease,From1 Jan 2014 → 31 Dec 2018Funding: IWT personal funding - strategic basic research grants
- Investigation of the role of GARP by using cell specific knockout miceFrom1 Oct 2013 → 12 Sep 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Unravelling the role of ADAMTS13 and anti-ADAMTS13 autoantibodies in the pathophysiology of thrombotic thrombocytopenic purpuraFrom1 Oct 2013 → 14 May 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Towards novel therapeutic strategies in ischemic stroke by targeting von Willebrand factor and promoting fibrinolysisFrom1 Mar 2013 → 13 Mar 2017Funding: BOF - Doctoral projects
- Towards better and safer thrombolytic therapy in acute ischemic stroke.From1 Jan 2013 → 31 Dec 2016Funding: FWO research project (including WEAVE projects)
- Specific contribution of transgene plasma and platelet von Willebrand factor in haemostasis and thrombosis: from functional studies to gene therapy.From1 Jan 2012 → 31 Dec 2015Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 141
- Pretreatment with a dual antiplatelet and anticoagulant (APAC) reduces ischemia-reperfusion injury in a mouse model of temporary middle cerebral artery occlusion-implications for neurovascular procedures(2024)
Authors: Simon De Meyer
- White blood cell subtypes and neutrophil extracellular traps content as biomarkers for stroke etiology in acute ischemic stroke clots retrieved by mechanical thrombectomy(2024)
Authors: Simon De Meyer
Pages: 1 - 8 - GENE THERAPY FOR VON WILLEBRAND DISEASE(2023)
Authors: Sarah Vandelanotte, Claudia Tersteeg, Simon De Meyer
Pages: 326 - 330 - Measuring ADAMTS-13 activity to diagnose thrombotic thrombocytopenic purpura: a novel, fast fiber-optic surface plasmon resonance immunoassay(2023)
Authors: Quintijn Bonnez, Peter Verhamme, Claudia Tersteeg, Simon De Meyer, Jeroen Lammertyn, Karen Vanhoorelbeke
- Mechanical thrombectomy for acute ischemic stroke revealing a cardiac myxoma: histological and immunohistochemical study to determine myxomatous emboli(2023)
Authors: Simon De Meyer
Pages: 1201 - 1203 - Small-Molecule Cyclophilin Inhibitors Potently Reduce Platelet Procoagulant Activity(2023)
Authors: Simon De Meyer, Karen Vanhoorelbeke, Claudia Tersteeg
- In vitro characterization of a novel Arg102 mutation in the ADAMTS13 metalloprotease domain(2023)
Authors: Claudia Tersteeg, Simon De Meyer, Karen Vanhoorelbeke
Pages: 682 - 690 - ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura(2023)
Authors: Kazuya Sakai, Laure De Waele, Claudia Tersteeg, Simon De Meyer, Karen Vanhoorelbeke
Pages: 131 - 140 - ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation(2022)
Authors: Shannen Deconinck, Christophe Vandenbriele, Bart Meyns, Claudia Tersteeg, Steven Jacobs, Simon De Meyer, Karen Vanhoorelbeke
Pages: 2797 - 2809 - Embotrap Extraction & Clot Evaluation & Lesion Evaluation for NeuroThrombectomy (EXCELLENT) Registry design and methods(2022)
Authors: Simon De Meyer
Pages: 783 - 787
Patents
1 - 5 of 5
- Dual targeting of tafi and pai-1 (Inventor)
- Dual targeting of tafi and pai-1 (Inventor)
- Compositions comprising adamts13 for use in methods for the recanalization of occluded blood vessels in an infarction (Inventor)
- Compositions comprising adamts13 for use in methods for the recanalization of occluded blood vessels in an infarction (Inventor)
- Dual targeting of tafi and pai-1 (Inventor)